603883
XSHG
Market cap1.62bUSD
Nov 20, Last price
14.37CNY
1D
-1.78%
1Q
8.86%
Jan 2017
-27.13%
IPO
30.87%
Name
LBX Pharmacy Chain JSC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
LBX Pharmacy Chain Joint Stock Company, headquartered in Changsha, China, oversees a substantial network of retail pharmacies throughout the country. Its operations span 21 distinct provincial markets across China, encompassing regions such as Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company, which commenced operations in 2001, was originally incorporated under the name Laobaixing Pharmacy Chain Joint Stock Company.
Key people
Zilong Xie
Chairman of the Board · since 2019
Li Wang
President · since 2023
Lishan Chen
Chief Financial Officer, Finance Director, Vice President · since 2026
Xian Dang
Vice President · since 2024
Xiaowei Guo
Vice President · since 2023
Yufei Jiang
Vice President · since 2021
Huan Lin
Vice President · since 2024
Shiyong Su
Vice President · since 2021
Xin Wan
Vice President · since 2022
Wenshuai Zhang
Vice President · since 2023
Shini Feng
Vice President, Secretary of the Board · since 2026
Zhen Li
Director · since 2022
Director · since 2018
Jiaqi Xie
Director · since 2024
Jiaqi Zheng
Director · since 2020
Mingchuan Ren
Independent Director · since 2024
Lianfeng Wu
Independent Director · since 2021
Ziqi Xie
Independent Director · since 2022
Headquarters & legal address
长沙市开福区青竹湖路808号
长沙市, HN 100000
CN
长沙市, HN 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||